Revenue: The sum of all revenue fields included for a company's operating activities.
Helix Biopharma Corp. (HBPCF) Revenue data is not available for the most recently reported fiscal year, ending 2024-07-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-6.82M |
|
-- |
|
-- |
|
$6.80M |
|
$-6.80M |
|
$-0.02M |
|
$-6.82M |
|
$-6.82M |
|
$-6.82M |
|
$-6.82M |
|
$-6.82M |
|
$-6.82M |
|
$-6.80M |
|
$-6.79M |
|
44.49M |
|
44.49M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$1.07M |
|
$0.02M |
|
$0.02M |
|
$1.10M |
|
$1.16M |
|
-- |
|
-- |
|
$1.16M |
|
$-0.07M |
|
$-0.07M |
|
$-0.07M |
|
49.02M |
|
| Cash Flow Statement Financials | |
$-3.84M |
|
$-0.01M |
|
$4.05M |
|
$0.59M |
|
$0.80M |
|
$0.20M |
|
$2.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10292.16% |
|
10293.33% |
|
-622.16% |
|
10293.33% |
|
$-0.00 |
|
$-0.09 |
|
$-0.09 |
|